Home > PS Ratio > GUFIC BIOSCIENCES

GUFIC BIOSCIENCES
PS (Price/Sales) Ratio

The Current P/S Ratio of GUFIC BIOSCIENCES is 3.62.

Share Price ₹283.2Mar 28,2024
Market Cap ₹2,840.0 Cr
Sales-TTM₹784.7 CrTTM-Standalone Results
Price/Sales3.62xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GUFIC BIOSCIENCES
Please provide your vote to see the results
GUFIC BIOSCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of GUFIC BIOSCIENCES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GUFIC BIOSCIENCES is calculated as :

Current Market Cap [ ₹2,840.0 Cr] as on Mar 28,2024

(/) Sales [ ₹784.7 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 3.62x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GUFIC BIOSCIENCES , the investors are currently willing to pay '3.62 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GUFIC BIOSCIENCES !

The chart below summarizes the trend in P/S Ratio of GUFIC BIOSCIENCES over the last five years.

Historical PS (Price/Sales) ratio chart of GUFIC BIOSCIENCES


PS Ratio Performance Analysis for GUFIC BIOSCIENCES

- GUFIC BIOSCIENCES 's latest p/e ratio is 3.62x.

- GUFIC BIOSCIENCES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.18x.

- GUFIC BIOSCIENCES 's operated at median p/e ratio of 2.27x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GUFIC BIOSCIENCES 's p/e ratio peaked in Mar2022 at 3.1x.

- GUFIC BIOSCIENCES 's p/e ratio hit its five-year low in Mar2020 of 1.21x.


How does GUFIC BIOSCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GUFIC BIOSCIENCES 784.73.622,840.0
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.68.20388,812.0
CIPLA LTD25,350.24.76120,673.0
DR REDDYS LABORATORIES LTD27,212.53.77102,679.0
ZYDUS LIFESCIENCES LTD19,024.25.32101,152.0
DIVIS LABORATORIES LTD7,492.812.1891,234.9
MANKIND PHARMA LTD9,946.39.2592,029.2
TORRENT PHARMACEUTICALS LTD10,474.08.4188,034.7
LUPIN LTD19,480.13.7873,722.0
AUROBINDO PHARMA LTD27,894.72.2963,835.1
ABBOTT INDIA LTD5,753.49.9557,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GUFIC BIOSCIENCES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.29x
Max industry PS 12.18x
Median industry PS 5.32x
Average industry PS 6.50x



You may also like the below Video Courses